Featured Speaker: Kevin Scanlon, Chairman of Pasadena Angels Investment Group.
About our speaker: Dr. Kevin J. Scanlon’s career includes: academic medicine, senior management in the pharmaceutical industry, a CEO in four start-up companies and an angel investor. He is the Chairman of Pasadena Angels Investment Group. Kevin is also an executive member of the Los Angeles Network of the Tech Coast Angels. Dr. Scanlon has worked with governments in Ireland, China and New Zealand to create an innovative culture at their universities. He is currently the CEO of the stem cell technology company, Makucell. As a Vice President at Berlex-Schering (Germany), he was responsible for their cancer program in the US, Europe and Asia. He is also on the faculty and an advisor for the FEMBA program at UCLA School of Management. Dr. Scanlon received his Ph.D. degree from the University of London in Molecular Biology and trained in Cancer Research at Yale Medical School. He was a Leukemia Society Scholar, awarded the Paul Martini Medical Research Prize in Cancer (Germany), the past President of the International Society of Cell and Cancer Gene Therapy (England), a participant at 400th Anniversary of Uppsala University (Sweden), he is an advisor at the National Institute for Cellular Biotechnology (Ireland), Co-Editor/Co-Founder of the Nature journal “Cancer Gene Therapy”, co-authored over 135 original scientific articles, edited nine medical books and has seven issued patents.
Specialties: Life Science, Biotechnology, management and science.